Format
Sort by
Items per page

Send to

Choose Destination

Best matches for PROPRANOLOL/PD:

Propranolol therapy for infantile hemangioma: our experience. Zhang L et al. Drug Des Devel Ther. (2017)

When to stop propranolol for infantile hemangioma. Chang L et al. Sci Rep. (2017)

Safety and effectiveness of propranolol in severely burned patients: systematic review and meta-analysis. Manzano-Nunez R et al. World J Emerg Surg. (2017)

Search results

Items: 1 to 20 of 23535

1.

Individualized dosing of oral propranolol for treatment of infantile hemangioma: a prospective study.

Prasad A, Sinha AK, Kumar B, Prasad A, Kumari M.

Pan Afr Med J. 2019 Apr 8;32:155. doi: 10.11604/pamj.2019.32.155.16760. eCollection 2019.

2.

Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications.

Pessoa TL, Clemente Junior WS, Costa TXD, Bezerra PKDV, Martins RR.

Einstein (Sao Paulo). 2019 May 30;17(3):eAO4521. doi: 10.31744/einstein_journal/2019AO4521. English, Portuguese.

3.

Effect of the rigidification of propranolol, a mixed β-adrenoceptor and 5-HT1AR antagonist.

Franchini S, Sorbi C, Linciano P, Brasili L, Tait A.

Pharmazie. 2019 Mar 1;74(3):131-135. doi: 10.1691/ph.2019.8878.

PMID:
30961676
4.

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.

Villanueva C, Albillos A, Genescà J, Garcia-Pagan JC, Calleja JL, Aracil C, Bañares R, Morillas RM, Poca M, Peñas B, Augustin S, Abraldes JG, Alvarado E, Torres F, Bosch J.

Lancet. 2019 Apr 20;393(10181):1597-1608. doi: 10.1016/S0140-6736(18)31875-0. Epub 2019 Mar 22. Erratum in: Lancet. 2019 Jun 22;393(10190):2492.

PMID:
30910320
5.

Release Adjustment of Two Drugs with Different Solubility Combined in a Matrix Tablet.

Chaerunisaa AY, Ali R, Dashevskiy A.

AAPS PharmSciTech. 2019 Mar 14;20(4):142. doi: 10.1208/s12249-019-1294-2.

PMID:
30874996
6.

Serotonin syndrome unmasking thyrotoxicosis.

Ronan GP, Ronan N, McGettigan S, Browne G.

BMJ Case Rep. 2019 Mar 7;12(3). pii: e228404. doi: 10.1136/bcr-2018-228404.

PMID:
30850570
7.

Propranolol selectively inhibits cervical cancer cell growth by suppressing the cGMP/PKG pathway.

Gong L, Lei Y, Tan X, Dong Y, Luo Z, Zhang D, Han S.

Biomed Pharmacother. 2019 Mar;111:1243-1248. doi: 10.1016/j.biopha.2019.01.027. Epub 2019 Jan 15.

8.

Exendin-4 Exacerbates Burn-Induced Morbidity in Mice by Activation of the Sympathetic Nervous System.

Ji XJ, Hao JW, Li GL, Dong N, Wang XQ, Zhou M, Zhang QH, Yao YM.

Mediators Inflamm. 2019 Jan 17;2019:2750528. doi: 10.1155/2019/2750528. eCollection 2019.

9.

MiR-187-3p Enhances Propranolol Sensitivity of Hemangioma Stem Cells.

Liu C, Zhao Z, Ji Z, Jiang Y, Zheng J.

Cell Struct Funct. 2019 Mar 20;44(1):41-50. doi: 10.1247/csf.18041. Epub 2019 Feb 2.

10.

Design and optimization of kollicoat ® IR based mucoadhesive buccal film for co-delivery of rizatriptan benzoate and propranolol hydrochloride.

Salehi S, Boddohi S.

Mater Sci Eng C Mater Biol Appl. 2019 Apr;97:230-244. doi: 10.1016/j.msec.2018.12.036. Epub 2018 Dec 12.

PMID:
30678908
11.

Safety assessment during initiation and maintenance of propranolol therapy for infantile hemangiomas.

Babiak-Choroszczak L, Giżewska-Kacprzak K, Dawid G, Gawrych E, Bagłaj M.

Adv Clin Exp Med. 2019 Mar;28(3):381-390. doi: 10.17219/acem/94136.

12.

A pharmacological composition for induction of a reversible torpor-like state and hypothermia in rats.

Zakharova NM, Tarahovsky YS, Fadeeva IS, Komelina NP, Khrenov MO, Glushkova OV, Prokhorov DA, Kutyshenko VP, Kovtun AL.

Life Sci. 2019 Feb 15;219:190-198. doi: 10.1016/j.lfs.2019.01.023. Epub 2019 Jan 16.

PMID:
30658098
13.

Prostaglandin E2 mediates sensory nerve regulation of bone homeostasis.

Chen H, Hu B, Lv X, Zhu S, Zhen G, Wan M, Jain A, Gao B, Chai Y, Yang M, Wang X, Deng R, Wang L, Cao Y, Ni S, Liu S, Yuan W, Chen H, Dong X, Guan Y, Yang H, Cao X.

Nat Commun. 2019 Jan 14;10(1):181. doi: 10.1038/s41467-018-08097-7.

14.

Effect of electrolytes on the simultaneous electrochemical oxidation of sulfamethoxazole, propranolol and carbamazepine: behaviors, by-products and acute toxicity.

García-Espinoza JD, Mijaylova Nacheva P.

Environ Sci Pollut Res Int. 2019 Mar;26(7):6855-6867. doi: 10.1007/s11356-018-4020-9. Epub 2019 Jan 11.

PMID:
30635885
15.

Edible solid foams as porous substrates for inkjet-printable pharmaceuticals.

Iftimi LD, Edinger M, Bar-Shalom D, Rantanen J, Genina N.

Eur J Pharm Biopharm. 2019 Mar;136:38-47. doi: 10.1016/j.ejpb.2019.01.004. Epub 2019 Jan 8.

PMID:
30630061
16.

No Increased Risks Associated with Propranolol Treatment for Infantile Hemangioma in Preterm Infants were Identified at 3 Years of Age.

Li L, Wei L, Xu ZG, Ma L.

Am J Clin Dermatol. 2019 Apr;20(2):289-293. doi: 10.1007/s40257-018-00419-1.

PMID:
30618026
17.

[What's new in pediatric dermatology?]

Mazereeuw-Hautier J.

Ann Dermatol Venereol. 2018 Dec;145 Suppl 7:VIIS32-VIIS46. doi: 10.1016/S0151-9638(18)31287-0. Review. French.

PMID:
30583755
18.

The role of freshwater copepods in the environmental risk assessment of caffeine and propranolol mixtures in the surface water bodies of Spain.

Di Lorenzo T, Castaño-Sánchez A, Di Marzio WD, García-Doncel P, Nozal Martínez L, Galassi DMP, Iepure S.

Chemosphere. 2019 Apr;220:227-236. doi: 10.1016/j.chemosphere.2018.12.117. Epub 2018 Dec 18.

PMID:
30583214
19.
20.

Recurrent bloody stools associated with visceral infantile haemangioma in a preterm twin girl.

Krick J, Riehle K, Chapman T, Chabra S.

BMJ Case Rep. 2018 Dec 3;11(1). pii: bcr-2018-226564. doi: 10.1136/bcr-2018-226564.

PMID:
30567166

Supplemental Content

Loading ...
Support Center